Cadralazine
CAS No. 64241-34-5
Cadralazine( ISF-2469 | ISF 2469 | ISF2469 )
Catalog No. M27862 CAS No. 64241-34-5
Cadralazine is a peripheral arteriolar vasodilator and can be used in studies about acting as an antihypertensive drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 62 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 212 | In Stock |
|
| 50MG | 333 | In Stock |
|
| 100MG | 473 | In Stock |
|
| 200MG | 642 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCadralazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCadralazine is a peripheral arteriolar vasodilator and can be used in studies about acting as an antihypertensive drug.
-
DescriptionCadralazine is a peripheral arteriolar vasodilator and can be used in studies about acting as an antihypertensive drug.
-
In Vitro——
-
In Vivo——
-
SynonymsISF-2469 | ISF 2469 | ISF2469
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64241-34-5
-
Formula Weight283.332
-
Molecular FormulaC12H21N5O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (882.36 mM)
-
SMILESCCOC(=O)NNc1ccc(nn1)N(CC)CC(C)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tawari NR, Degani MS. Pharmacophore mapping and electronic feature analysis for a series of nitroaromatic compounds with antitubercular activity. J Comput Chem. 2010 Mar;31(4):739-51.
molnova catalog
related products
-
Vercirnon
Vercirnon is a selective and potent antagonist of CCR9 (IC50: 10 nM). It is also used in the research of inflammatory bowel diseases.
-
Nicotinoyl azide
Nicotinoyl azide is a probe of light-activated chemical. It has been used to measure the solvent accessibility of purine nucleobases.
-
Dehydrodiconiferyl a...
Dehydrodiconiferyl alcohol (DHCA) is a lignan isolated from calabash that inhibits osteoclast differentiation and oophorectomy induced bone loss by acting as an estrogen receptor agonist.
Cart
sales@molnova.com